| Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 2 Dec 24 | ALXO ALX Oncology | Common Stock | Buy | Acquire P | No | No | 1.5468 | 30,000 | 46.40 k | 33,000 |
| 25 Sep 24 | BIOA BioAge Labs | Stock Option Common Stock | Grant | Acquire A | No | No | 18 | 15,000 | 270.00 k | 15,000 |
| 13 Jun 24 | ALXO ALX Oncology | Stock Option Common Stock | Grant | Acquire A | No | No | 8.44 | 20,200 | 170.49 k | 20,200 |
| 11 Jun 24 | MXCT MaxCyte | Common Stock | Grant | Acquire A | No | No | 0 | 21,367 | 0.00 | 21,367 |
| 11 Jun 24 | MXCT MaxCyte | Stock Option Common Stock | Grant | Acquire A | No | No | 4.68 | 40,701 | 190.48 k | 40,701 |
| 17 Apr 24 | BIOA BioAge Labs | Stock Option Common Stock | Grant | Acquire A | No | No | 8.39 | 28,497 | 239.09 k | 28,497 |
